IODOTOPE
LOE ApproachingNDAORALCAPSULE
Approved
May 1957
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IODOTOPE is an oral capsule pharmaceutical product approved in 1957 by Bracco, representing a legacy therapeutic agent with a well-established clinical history. The specific mechanism of action and indication are not disclosed in available data, but the oral capsule formulation suggests systemic therapeutic utility. This product falls into the NDA (New Drug Application) category and operates as a small molecule therapeutic.
LOE Approaching
Product is approaching loss of exclusivity with moderate competitive pressure (30%), suggesting a shrinking commercial footprint and likely reduction in team investment and headcount.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
IODOTOPE currently has zero linked job openings, reflecting its LOE-approaching status and diminished commercial priority. Career roles on this product are primarily in legacy brand management and generic defense rather than growth-focused activities.
Brand ManagerField Sales Representative
Worked on IODOTOPE at Bracco? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.